-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Eloxx Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2010 to 2022.
- Eloxx Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$6.81M, a 28.2% increase year-over-year.
- Eloxx Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$31.8M, a 9.02% increase from 2021.
- Eloxx Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$35M, a 24.3% decline from 2020.
- Eloxx Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$28.2M, a 28.5% increase from 2019.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)